| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.81B | 36.91B | 36.58B | 36.01B | 33.89B | 45.54B |
| Gross Profit | 9.20B | 9.25B | 9.50B | 8.69B | 8.65B | 7.64B |
| EBITDA | 5.73B | 5.76B | 5.52B | 4.35B | 4.36B | 3.82B |
| Net Income | 2.50B | 2.57B | 2.60B | 2.25B | 2.34B | 1.23B |
Balance Sheet | ||||||
| Total Assets | 55.35B | 53.01B | 55.15B | 51.23B | 50.08B | 50.95B |
| Cash, Cash Equivalents and Short-Term Investments | 5.73B | 4.95B | 2.92B | 3.97B | 3.77B | 5.55B |
| Total Debt | 3.41B | 1.28B | 2.01B | 3.06B | 4.38B | 7.89B |
| Total Liabilities | 18.25B | 15.53B | 18.37B | 18.05B | 19.17B | 21.97B |
| Stockholders Equity | 37.09B | 37.48B | 36.77B | 33.18B | 30.90B | 28.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.29B | 377.00M | 989.00M | 2.02B | 2.86B |
| Operating Cash Flow | 0.00 | 4.70B | 2.15B | 2.06B | 3.06B | 4.19B |
| Investing Cash Flow | 0.00 | -991.00M | -1.37B | -65.00M | -984.00M | -1.14B |
| Financing Cash Flow | 0.00 | -1.70B | -1.84B | -1.78B | -3.98B | -2.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥56.75B | 9.61 | ― | 1.92% | -0.86% | 17.65% | |
75 Outperform | ¥51.24B | 50.64 | 9.07% | 4.46% | -1.14% | 34.15% | |
73 Outperform | ¥55.20B | 8.68 | ― | 4.32% | -31.99% | -44.75% | |
70 Outperform | ¥85.34B | 10.34 | ― | 3.74% | -0.68% | -9.93% | |
65 Neutral | ¥266.94B | 11.03 | 9.45% | 2.65% | -0.04% | 3.15% | |
63 Neutral | ¥212.75B | 10.31 | 6.95% | 3.06% | -7.36% | -574.56% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |